Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Bone Loss, Osteoclastic

17-alpha-hydroxyprogesterone has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diederich, S; Koetz, KR; Quinkler, M; van Rossum, EF; Ventz, M1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Bone Loss, Osteoclastic

ArticleYear
BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Clinical endocrinology, 2013, Volume: 78, Issue:6

    Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Androstenedione; Bone Density; Bone Resorption; Collagen; Collagen Type I; Cross-Sectional Studies; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Middle Aged; Peptides; Polymorphism, Genetic; Prospective Studies; Receptors, Glucocorticoid

2013